| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |